Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Kodiak Sciences
KOD
$2.72B
| $3.55M | ﹤0.01% |
+49,300
| New | +$1.79M |
|
1377
Hilltop Holdings
HTH
$2.25B
| $3.54M | ﹤0.01% |
142,100
+1,000
| +0.7% | +$24.4K |
|
1378
Enviri
NVRI
$583M
| $3.54M | ﹤0.01% |
153,700
+3,200
| +2% | +$66.9K |
|
1379
Capitol Federal Financial
CFFN
$1.1B
| $3.53M | ﹤0.01% |
257,200
+5,000
| +2% | +$70.4K |
|
1380
Comfort Systems
FIX
$61.2B
| $3.52M | ﹤0.01% |
70,600
+1,400
| +2% | +$68.1K |
|
|
PRMW
1381
DELISTED
Primo Water Corporation
PRMW
| $3.52M | ﹤0.01% |
257,600
| – | – |
|
1382
Otter Tail
OTTR
$3.87B
| $3.51M | ﹤0.01% |
68,500
+1,400
| +2% | +$72.7K |
|
1383
NETSCOUT
NTCT
$2.87B
| $3.5M | ﹤0.01% |
145,328
+500
| +0.3% | +$11.8K |
|
1384
Westamerica Bancorp
WABC
$1.38B
| $3.5M | ﹤0.01% |
51,600
+1,100
| +2% | +$71.9K |
|
|
RWT
1385
Redwood Trust
RWT
$592M
| $3.49M | ﹤0.01% |
211,000
+5,800
| +3% | +$95.3K |
|
1386
Bloomin' Brands
BLMN
$975M
| $3.48M | ﹤0.01% |
157,900
-6,000
| -4% | -$127K |
|
1387
Onto Innovation
ONTO
$20.6B
| $3.48M | ﹤0.01% |
95,241
+52,041
| +120% | +$1.77M |
|
1388
8x8 Inc
EGHT
$290M
| $3.48M | ﹤0.01% |
190,100
+9,400
| +5% | +$181K |
|
1389
Galicia Financial Group
GGAL
$7.1B
| $3.48M | ﹤0.01% |
214,303
-91,300
| -30% | -$1.21M |
|
|
SCS
1390
DELISTED
Steelcase
SCS
| $3.48M | ﹤0.01% |
170,000
+3,600
| +2% | +$66.7K |
|
|
MGLN
1391
DELISTED
Magellan Health Services, Inc.
MGLN
| $3.47M | ﹤0.01% |
44,400
+1,600
| +4% | +$113K |
|
1392
Jack in the Box
JACK
$358M
| $3.47M | ﹤0.01% |
44,500
+900
| +2% | +$74.5K |
|
|
DOOR
1393
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $3.46M | ﹤0.01% |
47,877
-200
| -0.4% | -$13.1K |
|
1394
Healthcare Services Group
HCSG
$1.43B
| $3.45M | ﹤0.01% |
141,863
+2,700
| +2% | +$66.9K |
|
|
AYR
1395
DELISTED
Aircastle Ltd
AYR
| $3.44M | ﹤0.01% |
107,600
+1,900
| +2% | +$54.9K |
|
|
WW
1396
DELISTED
WW International
WW
| $3.44M | ﹤0.01% |
90,100
+1,800
| +2% | +$68.3K |
|
1397
Horace Mann Educators
HMN
$2.09B
| $3.44M | ﹤0.01% |
78,800
+1,500
| +2% | +$66.3K |
|
1398
Coeur Mining
CDE
$19B
| $3.44M | ﹤0.01% |
425,200
+40,300
| +10% | +$249K |
|
|
EPZM
1399
DELISTED
Epizyme, Inc
EPZM
| $3.43M | ﹤0.01% |
139,500
+3,100
| +2% | +$46K |
|
1400
Ambarella
AMBA
$3.66B
| $3.41M | ﹤0.01% |
56,333
+1,100
| +2% | +$60.9K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.